NCT06824116

Brief Summary

The aim of this randomised experimental study is to test the effect of different intensities of aerobic exercise on neurotrophin concentration and functional and cognitive functions in post-stroke patients undertaking a single bout and 3-week exercise programme. The main questions to answer are:

  • blood samples collection (to measure level of brain-derived neurotrophic factor, glial cell derived neurotrophic factor, insulin-like growth factor, vascular-endothelial growth factor, irisin),
  • body mass index
  • The Graded Cycling Test with Talk Test
  • 6-Minute Walk Test
  • Rivermead Motor Assessment
  • Barthel Index
  • Addenbrooke's Cognitive Examination
  • Vo2max
  • Beck Depression Inventory Researchers will compare two groups - moderate intensity continuous group and low intensity continuous group to see if there is a modulating effect of different intensities of exercise in participants' outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2021

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2021

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

February 7, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 13, 2025

Completed
Last Updated

February 13, 2025

Status Verified

January 1, 2025

Enrollment Period

7 months

First QC Date

February 7, 2025

Last Update Submit

February 7, 2025

Conditions

Keywords

strokecognitive functionsneurotrophinsneurological rehabilitation

Outcome Measures

Primary Outcomes (12)

  • Brain-derived neurotrophic factor

    Level of brain-derived neurotrophic factor in ng/ml

    Before and after 3-week intervention; pre and post single bout of exercise in the first day of intervention

  • Glial cell derived neurotrophic factor

    Level of glial cell derived neurotrophic factor in ng/ml

    Before and after 3-week intervention; pre and post single bout of exercise in the first day of intervention

  • Insulin-like growth factor

    Level of insulin-like growth factor in ng/ml

    Before and after 3-week intervention; pre and post single bout of exercise in the first day of intervention

  • irisin

    Level of irisin in ng/ml

    Before and after 3-week intervention; pre and post single bout of exercise in the first day of intervention

  • Vascular-endothelial growth factor A

    Level of Vascular-endothelial growth factor A in ng/ml

    Before and after 3-week intervention; pre and post single bout of exercise in the first day of intervention

  • The Graded Cycling Test with Talk Test

    Cardiorespiratory fitness assessment with the Graded Cycling Test with Talk Test assess submaximal exercise in Watt. Higher Watt means better outcome.

    Before and after 3-week intervention

  • Vo2max

    Physical performance assessment with Vo2max in mL/min/kg.

    Before and after 3-week intervention

  • Six Minute Walk Test

    The 6 minute walking test assesses functional capacity during continuous walking on a 12-m ward hallway for 6 min. The test measures the distance a patient walks in 6 min.

    Before and after 3-week intervention

  • Rivermead Motor Assessment

    Functional mobility among post-stroke patients was assessed with the Rivermead Motor Assessment, a performance-based measure in points. This later includes 38 items that cover three sections: gross function, leg and trunk and arm function. The total score ranges from 0 to 38 points. Higher scores indicate a higher degree of functional mobility.

    Before and after 3-week intervention

  • Barthel Index

    The Barthel Index is a scale that measures an individual's functional outcomes. It consists of 10 items that assess activities of daily living, functional mobility, and gait. The score ranges from 0 to 100 points. The higher the score, the greater the individual's ability to self-care

    Before and after 3-week intervention

  • Addenbrooke's Cognitive Examination

    Cognitive functions assessment with Addenbrooke's Cognitive Examination in points. Higher scores means better outcome.

    Before and after 3-week intervention

  • Beck Depression Inventory

    Depressive symptoms assessment with Beck Depression Inventory in points. Higher scores means worse outcome.

    Before and after 3-week intervention

Study Arms (2)

exercise low intensity

ACTIVE COMPARATOR
Behavioral: Exercise

exercise moderate intensity

EXPERIMENTAL
Behavioral: Exercise

Interventions

ExerciseBEHAVIORAL

Training on a bicycle ergometer was performed four times a week for 3 weeks for 45 min. The exercise intensity corresponded to 50%-60% of maximal oxygen uptake (VO2max).

exercise low intensity

Eligibility Criteria

Age21 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 21-75 years,
  • first episode of ischemic stroke confirmed by magnetic resonance imaging (MRI) or computed tomography (CT),
  • able to walk for 4 m at a self-selected speed independently or with an assistive device (as needed),
  • be in a stable clinical condition,
  • able to communicate with investigators,
  • provided written informed consent to participate in the study.

You may not qualify if:

  • aphasia,
  • an unstable cardiac status (e.g., evidence of significant arrhythmia or myocardial ischaemia),
  • lower extremity claudication,
  • weight-bearing pain \>4/10,
  • lower extremity spasticity (i.e., an Ashworth Scale score \>2), other neurological conditions in addition to stroke,
  • chronic degenerative or inflammatory diagnoses, malignancies, and visuospatial neglect.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Physiology

Poznan, 61-871, Poland

Location

MeSH Terms

Conditions

Ischemic StrokeStroke

Interventions

Exercise

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2025

First Posted

February 13, 2025

Study Start

June 1, 2021

Primary Completion

December 20, 2021

Study Completion

December 30, 2021

Last Updated

February 13, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations